Financial disclosure lacking in publication of clinical trials
A substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in…
Browsing: clinical trials
New drug halves hearing loss in children following cancer treatment
Giving the drug sodium thiosulphate after chemotherapy reduces hearing loss in children treated for liver…
Translating Research and Biomarkers
By Ian Olver AM for oncologynews.com.au The term translational research is broad but most often…
It’s time to rethink how we do cancer research
Eileen Parkes, Academic Clinical Lecturer, Queen’s University Belfast “A devastating failure of medical research.” This…
Expert Review: COSA Public Forum 2017
A small but enthusiastic group of people gathered on the eve of the COSA ASM…
The importance of returning results to study participants
Researchers from Garvan and the Australian Pancreatic Cancer Genome Initiative have explored the feasibility and…
Giving children a voice in clinical trials
Children as young as 8 years old with incurable cancer can reliably characterise the impact…
SIRT better tolerated than sorafenib, but doesn’t increase overall survival in HCC
Results of the SARAH trial presented today demonstrate that SIRT resulted in median overall survival…
New era in precision medicine for pancreatic cancer
The development of new treatments for pancreatic cancer is set to be transformed by a network of…
New conference showcases the impact of clinical trials
A new Sydney conference will focus on improving collaboration across phase one clinical trials in…